Spermosens AB (publ) (NGM:SPERM)

Market Cap	27.92M +29.4%
Revenue (ttm)	n/a
Net Income	-9.43M
EPS	-0.00
Shares Out	3.17B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	563,715
Open	0.0088
Previous Close	0.0088
Day's Range	0.0084 - 0.0088
52-Week Range	0.0042 - 0.0120
Beta	0.11
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Spermosens AB

Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2018
• Employees: 3
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: SPERM

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 9, 2026

Data Sources Report a data error